The purpose of this paper was to determine the effect of prostate cancer diagnosis, freeze-thaw cycling, thaw temperature/duration and microRNA (miRNA, miR) extraction kit on the quantification of miR21-5p, miR-93-5p miR-451a, miR-223-3p, and miR-23a-3p in serum.
Standardizing analysis of circulating microRNA: clinical and biological relevance.
Farina NH, Wood ME, Perrapato SD, Francklyn CS, Stein GS, Stein JL, Lian JB
Purpose
Conclusion
miR-21-5p and miR-93-5p levels were higher and more variable in the serum of patients with prostate cancer than in healthy controls. Specimens thawed twice on ice (for 1-2h) had slightly higher levels of miR-21-5p and miR-23a-3p compared to controls that were thawed once. When specimens were thawed for a second time at 37°C for 30-60 sec, levels of miR-93-5p and miR-451a increased further.
Studies (1)
Purpose
The purpose of this study was to determine the effect of prostate cancer diagnosis, freeze-thaw cycling, and thaw temperature/duration on the quantification of miR21-5p, miR-93-5p miR-451a, miR-223-3p, and miR-23a-3p in serum. Serum obtained from 11 healthy men and 10 men with prostate cancer was aliquoted and stored at -80°C. Serum was thawed on ice for 1-2 h, and aliquoted for immediate extraction or for repeat freezing at -80°C and thawing on ice (slow) or at 37°C (fast) before RNA extraction. RNA was extracted using modifications to the mirVana PARIS or miRNeasy Serum/Plasma kits. The freeze-thaw experiments only included the serum from 6 healthy men and statistical significance was not presented.
Summary of Findings
miR-21-5p and miR-93-5p levels were higher and more variable in serum from patients with prostate cancer than from healthy controls (p<0.01 and p<0.001, respectively). Compared to specimens thawed once, specimens thawed twice on ice (1-2h each time) had slightly higher levels of miR-21-5p and miR-23a-3p. When specimens were thawed for a second time at 37°C for 30-60 sec, levels of miR-93-5p and miR-451a were higher than in specimens subjected to 1 freeze-thaw cycle.
Biospecimens
FluidSerumPreservation Types
FrozenDiagnoses
NeoplasticCarcinomaNormalPlatforms
RNAReal-time qRT-PCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition HealthyProstate cancerStorage Freeze/thaw cycling 1 cycle2 cyclesStorage Thaw duration 1-2 h30-60 sStorage Thaw temperature/condition 37°COn iceReal-time qRT-PCR Specific Targeted nucleic acid miR-21-5pmiR-23a-3pmiR-451amiR93-5p